{"id":2248,"date":"2017-12-18T17:26:01","date_gmt":"2017-12-18T17:26:01","guid":{"rendered":"https:\/\/www.medicalmarijuanainc.com\/?p=33516"},"modified":"2017-12-18T17:26:01","modified_gmt":"2017-12-18T17:26:01","slug":"medical-marijuana-inc-subsidiary-hempmeds-mexico-announces-international-news-coverage-benefits-cbd-u-n-s-global-cbd-policy","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2017\/12\/18\/medical-marijuana-inc-subsidiary-hempmeds-mexico-announces-international-news-coverage-benefits-cbd-u-n-s-global-cbd-policy\/","title":{"rendered":"Medical Marijuana, Inc. Subsidiary HempMeds\u00ae Mexico Announces International News Coverage on Benefits of CBD, U.N.’s Global CBD Policy"},"content":{"rendered":"

SAN DIEGO, Dec. 18, 2017 —\u00a0Medical Marijuana, Inc.\u00a0(OTC:MJNA<\/a>), the first-ever publicly traded cannabis company in the United States, announced today that Ra\u00fal Elizalde, President of subsidiary\u00a0HempMeds\u00ae Mexico<\/a>, was recently featured in several international news publications about his speaking engagement at the World Health Organization Drug Scheduling Convention on Psychotropic Substances in November 2017.<\/p>\n

Elizalde, who’s campaign to help his epileptic daughter legalized cannabidiol (CBD) in Mexico, discussed how the substance is non-psychoactive, non-addictive and has no negative side effects. He shared his story about how CBD changed his family’s life for the better and how the World Health Organization’s recommendation has the potential to change many more lives across the globe.<\/p>\n

News publications Elizalde was featured in include:<\/p>\n